Cargando…

A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas

BACKGROUND: Lower-grade gliomas (LGGs) are less aggressive with a long overall survival (OS) time span. Because of individualized genomic features, a prognostic system incorporating molecular signatures can more accurately predict OS. METHODS: Differential expression analysis between LGGs and normal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yuxi, Peng, Zesheng, Gu, Sujie, Wang, Haofei, Xiang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856808/ https://www.ncbi.nlm.nih.gov/pubmed/35186111 http://dx.doi.org/10.1155/2022/2558548

Ejemplares similares

A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas
por: Pan, Xuyan, et al.
Publicado: (2021)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
por: Zhou, Yi, et al.
Publicado: (2023)

Identifying the Hub Genes of Glioma Peritumoral Brain Edema Using Bioinformatical Methods
por: Wu, Yuxi, et al.
Publicado: (2022)

Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma
por: Peng, Zesheng, et al.
Publicado: (2023)

A Novel Six Autophagy-Related Genes Signature Associated With Outcomes and Immune Microenvironment in Lower-Grade Glioma
por: Lin, Tao, et al.
Publicado: (2021)

Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma
por: Feng, Shaobin, et al.
Publicado: (2021)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Construction and Verification of a Glycolysis-Associated Gene Signature for the Prediction of Overall Survival in Low Grade Glioma
por: Liu, Wei, et al.
Publicado: (2022)

A novel risk score model based on fourteen chromatin regulators-based genes for predicting overall survival of patients with lower-grade gliomas
por: Zhang, Yongfeng, et al.
Publicado: (2022)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction
por: Qian, Zenghui, et al.
Publicado: (2018)

An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemia
por: Kong, Weikaixin, et al.
Publicado: (2022)

Development of an Autophagy Score Signature for Predicting Overall Survival in Papillary Renal Cell Carcinoma
por: Gu, Xiang, et al.
Publicado: (2020)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

Identification of an epigenetic prognostic signature for patients with lower‐grade gliomas
por: Yu, Hai, et al.
Publicado: (2021)

N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2020)

A Risk Model Developed Based on Homologous Recombination Deficiency Predicts Overall Survival in Patients With Lower Grade Glioma
por: Peng, Hao, et al.
Publicado: (2022)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs
por: Chen, Shaohua, et al.
Publicado: (2021)

Combination genetic signature stratifies lower-grade gliomas better than histological grade
por: Chan, Aden Ka-Yin, et al.
Publicado: (2015)

PPP1R81 correlates with the survival and cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

Systematic Analysis of a Pyroptosis-Related Signature to Predict the Prognosis and Immune Microenvironment of Lower-Grade Glioma
por: He, Yongze, et al.
Publicado: (2022)

APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
por: Chen, Jiajin, et al.
Publicado: (2022)

Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas
por: Yan, Derui, et al.
Publicado: (2022)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer
por: Zhou, Min, et al.
Publicado: (2022)

A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2018)

Identification of purity and prognosis‐related gene signature by network analysis and survival analysis in brain lower grade glioma
por: Xiong, Zujian, et al.
Publicado: (2020)

Identification of a Six-Gene Signature for Predicting the Overall Survival of Cervical Cancer Patients
por: Huo, Xiao, et al.
Publicado: (2021)

The Clinical Frailty Scale as predictor of overall survival after resection of high-grade glioma
por: Klingenschmid, Julia, et al.
Publicado: (2022)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas
por: Zhao, Xu, et al.
Publicado: (2022)

Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics
por: Zhang, Zihao, et al.
Publicado: (2022)

Ferroptosis‐related gene signature as a prognostic marker for lower‐grade gliomas
por: Zheng, Yi, et al.
Publicado: (2021)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

A Novel Insight into Paraptosis-Related Classification and Signature in Lower-Grade Gliomas
por: Qian, Xi-Feng, et al.
Publicado: (2022)

Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas
por: Powell, Reid Trenton, et al.
Publicado: (2017)

Construction of a prognostic immune signature for lower grade glioma that can be recognized by MRI radiomics features to predict survival in LGG patients
por: Li, Zi-zhuo, et al.
Publicado: (2021)

Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma
por: Cao, Yubo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q9bqvsgj73e9lt76r9o8ptv4cg